4//SEC Filing
Noble James 4
Accession 0001104659-21-088969
CIK 0001621227other
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 5:02 PM ET
Size
5.5 KB
Accession
0001104659-21-088969
Insider Transaction Report
Form 4
Noble James
DirectorChief Executive Officer
Transactions
- Award
Option to purchase Ordinary Shares
2021-07-01+379,788→ 379,788 totalExercise: $0.71From: 2022-07-01Exp: 2031-07-01→ Ordinary Shares (379,788 underlying)
Footnotes (1)
- [F1]The exercise price was converted from GBP0.51 based on an exchange rate of $U.S. 1.3807 to GBP1.00. The actual exercise price will be the pounds sterling amount.
Documents
Issuer
Adaptimmune Therapeutics PLC
CIK 0001621227
Entity typeother
Related Parties
1- filerCIK 0001388000
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 5:02 PM ET
- Size
- 5.5 KB